Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost in the Treatment of Eyelash Hypotrichosis
2012-003007-35Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bimatoprost in eyelash hypotrichosis (3 arms), sponsored by Allergan. Started Dec 2012; status: completed.
02
Drugs
bimatoprost
03
Conditions
eyelash hypotrichosis
Beyond the preview
Go deeper on 2012-003007-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003007-35.